Phenotypic reversal of MeCP2 deficiency was achieved by restoring MeCP2 function in a RTT syndrome mouse model (MeCP2 knockout) [7], as well by systemic administration of an adeno-associated virus bearing MeCP2 cDNA [8], suggesting that RTT may be potentially treatable in humans. Here, MECP2 is linked to Rett syndrome.